University of California San Francisco
Give to UCSF
A rare burst of visual creativity is seen occasionally in patients with frontotemporal dementia. A UCSF-led study offers new insights into how this talent develops as key areas of the brain degenerate.
UCSF is helping to create the first large group of Asian American study participants to help improve Alzheimer’s disease care for the Asian community North America.
UCSF researchers tested nitroglycerin patches, an treatment for chest pain from coronary artery disease, for menopausal hot flashes. Short-term benefits were seen, but not long-term as some side effects occurred.
Exposure to trichloroethylene (TCE), a chemical found in the air, water, and soil, may increase the risk of Parkinson's disease by 70%, according to a UCSF study. TCE is commonly used today as a degreasing solvent.
Saul Villeda, the 2023 recipient of the Byers Award, delivered a lecture titled "Blood Work and the Brain: Deciphering the Language of Cognitive Rejuvenation." His research focuses on understanding the biological mechanisms behind cognitive decline with age and exploring potential ways to reverse it.
What is “social prescribing” and what is UCSF doing to promote it? UCSF experts address the health ramifications of social isolation.
Emily Goldberg's lab studies what happens during aging to a particular set of immune cells: those embedded in fat tissue. She hypothesizes that changes to these cells during aging could be key to age-related inflammation.
Leanne Jones, PhD, is at the forefront of studying how stem cells are influenced by their surrounding environment and directed to differentiate into one type of cell or another – research that’s critical for stem cell therapies to be successful.
Sleep medications may increase risk of dementia for white people, though the type and amount of medication may also explain the higher probability.
Sociologist Stacy Torres, PhD, studied a group of older adults that hung out at a Manhattan bakery. She reflects on what they taught her about survival and belonging.
UCSF experts discuss the current state of Alzheimer’s treatments and future therapies that may slow progression of the disease.
UCSF Experts Present Research at the Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference in San Francisco.
